{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:41:51Z","timestamp":1788327711853,"version":"build-2803163510"},"reference-count":17,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1136\/bjophthalmol-2017-310294","type":"journal-article","created":{"date-parts":[[2017,4,22]],"date-time":"2017-04-22T00:50:27Z","timestamp":1492822227000},"page":"1704-1708","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":28,"title":["Reduction of severe visual loss and complications following intra-arterial chemotherapy (IAC) for refractory retinoblastoma"],"prefix":"10.1136","volume":"101","author":[{"given":"M Ashwin","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zishan","family":"Naeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fergus","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Herod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Rennie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alki","family":"Liasis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy Ann","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep","family":"Sagoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,4,21]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2017-310294-1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaophthalmol.2015.3108","article-title":"Treatment of retinoblastoma in 2015: agreement and disagreement","volume":"133","author":"Abramson","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310294-2","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/jamaophthalmol.2016.0244","article-title":"Intra-arterial chemotherapy for retinoblastoma: a systematic review","volume":"134","author":"Yousef","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310294-3","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/IAE.0b013e318203c101","article-title":"Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma","volume":"31","author":"Munier","year":"2011","journal-title":"Retina"},{"key":"key-10.1136\/bjophthalmol-2017-310294-4","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archophthalmol.2011.150","article-title":"Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds","volume":"129","author":"Shields","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310294-5","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ophtha.2011.08.045","article-title":"Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma","volume":"119","author":"Muen","year":"2012","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2017-310294-6","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1136\/bjophthalmol-2013-303694","article-title":"Visual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate vision","volume":"97","author":"Tsimpida","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310294-7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ohc.2004.11.003","article-title":"Intraocular retinoblastoma: the case for a new group classification","volume":"18","author":"Linn Murphree","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"key":"key-10.1136\/bjophthalmol-2017-310294-8","first-page":"819","volume-title":"AJCC cancer staging manual","author":"Mallipatna","year":"2016","edition":"8"},{"key":"key-10.1136\/bjophthalmol-2017-310294-9","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/pan.12162","article-title":"Autonomic cardio-respiratory reflex reactions and superselective ophthalmic arterial chemotherapy for retinoblastoma","volume":"23","author":"Phillips","year":"2013","journal-title":"Paediatr Anaesth"},{"key":"key-10.1136\/bjophthalmol-2017-310294-10","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/archophthalmol.2011.5","article-title":"Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience","volume":"129","author":"Gobin","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310294-11","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1136\/bjophthalmol-2012-301925","article-title":"Three-drug intra-arterial chemotherapy using simultaneous carboplatin, topotecan and melphalan for intraocular retinoblastoma: preliminary results","volume":"96","author":"Marr","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310294-12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10633-009-9195-4","article-title":"ISCEV standard for clinical visual evoked potentials (2009 update)","volume":"120","author":"Odom","year":"2010","journal-title":"Doc Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310294-13","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jamaophthalmol.2015.2861","article-title":"Anterior segment seeding in eyes with retinoblastoma failing to respond to intraophthalmic artery chemotherapy","volume":"133","author":"Pavlidou","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310294-14","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3171\/2011.1.JNS10466","article-title":"Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors","volume":"114","author":"Peterson","year":"2011","journal-title":"J Neurosurg"},{"key":"key-10.1136\/bjophthalmol-2017-310294-15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10384-014-0356-y","article-title":"Selective ophthalmic arterial injection of melphalan for intraocular retinoblastoma: a 4-year review","volume":"59","author":"Ong","year":"2015","journal-title":"Jpn J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310294-16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10633-013-9416-8","article-title":"Non-selectivity of ERG reductions in eyes treated for retinoblastoma","volume":"128","author":"Liu","year":"2014","journal-title":"Doc Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310294-17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084247","article-title":"Electroretinogram monitoring of dose-dependent toxicity after ophthalmic artery chemosurgery in retinoblastoma eyes: six year review","volume":"9","author":"Francis","year":"2014","journal-title":"PLoS One"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2017-310294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:55:06Z","timestamp":1601110506000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2017-310294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,21]]},"references-count":17,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,11,23]]},"published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.1136\/bjophthalmol-2017-310294"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2017-310294","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,21]]}}}